This inventor holds 1 USPTO granted patent. Top assignee: The Brigham and Women's Hospital, Inc.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Innovator Krisztina Fischer and Her Groundbreaking Patent in Renal Disease Management
Introduction
Krisztina Fischer is a notable inventor based in Brookline, MA (US). She has made significant contributions to the field of medical technology, particularly in the area of renal disease management. Her innovative approach utilizes focused ultrasound to enhance glomerular function, offering new avenues for treatment.
Latest Patents
Krisztina Fischer holds a patent for a method titled "Method for modifying glomerular permeability and function with focused ultrasound." This patent describes a noninvasive technique that alters the permeability of specific tissues using low-power focused ultrasound (FUS). By administering a microbubble contrast agent, this method temporarily increases glomerular filtration, allowing for the clearance of larger molecules that are typically not filtered by the kidneys. This advancement presents promising treatment opportunities for patients suffering from renal diseases.
Career Highlights
Krisztina Fischer is affiliated with The Brigham and Women's Hospital, Inc., where she continues to develop her innovative ideas. Her work is characterized by a commitment to improving patient outcomes through advanced medical technologies.
Collaborations
Krisztina has collaborated with esteemed colleagues such as Nathan J McDannold and Ferenc A Jolesz. Their combined expertise has contributed to the success of her research and the development of her patented methods.
Conclusion
Krisztina Fischer's innovative work in modifying glomerular permeability through focused ultrasound represents a significant advancement in renal disease management. Her contributions are paving the way for new treatment options that could greatly benefit patients in need.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
